Search For "monoclonal"
Scientists develop engineered antibodies, paving way for non-hormonal cont
Updated : 4 years, 9 months ago IST
Washington [US], August 30 (ANI): Scientists at the University of North Carolina at Chapel Hill are using the precision targeting of monoclonal antibodies for a new type of female non-hormonal contraception.
Read More
Apart from Delta, Delta Plus too should be treated as variant of concern:
Updated : 4 years, 11 months ago IST
New Delhi [India], June 26 (ANI): Although there is no data as of now which shows that the Delta Plus variant of COVID-19 is spreading faster than Delta but the former should also be treated as a "variant of concern", said Dr Raman R Gangakhedkar, former Head Scientist of Epidemiology and Co
Read More
AstraZeneca's antibody treatment fails to protect against COVID-19
Updated : 4 years, 11 months ago IST
Moscow [Russia], June 15 (ANI/Sputnik): AstraZeneca announced on Tuesday that the clinical trial of its long-acting antibody cocktail has not provided evidence of effectiveness in protecting people exposed to the coronavirus.
Read More
COVID-19 'Delta Plus' variant detected in India, nullifies monoclonal anti
Updated : 4 years, 11 months ago IST
New Delhi [India], June 15 (ANI): The Union Health Ministry on Tuesday revealed that the Delta variant with an additional mutation known as "Delta Plus" has been detected in the country that nullifies the use of monoclonal antibody but asserted that it still not a "variant of concern". Read More
Delhi hospital achieves successful results on use of Monoclonal Antibody a
Updated : 4 years, 11 months ago IST
New Delhi [India], June 9 (ANI): Sir Ganga Ram Hospital of New Delhi has reported successful use of Monoclonal antibody in two patients with fast progression of symptoms within the first seven days. Both patients recovered and were discharged with 12 hours.
Read More
Monoclonal Antibody treatment begins at Delhi's LNJP hospital
Updated : 4 years, 12 months ago IST
New Delhi [India], June 6 (ANI): The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" patients who are Covid positive is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) free of cost.
Read More
Zydus Cadila, first Indian Company gets recommendation for clinical trials
Updated : 4 years, 12 months ago IST
New Delhi [India], June 4 (ANI): The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been recommended to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drug
Read More
Two high risk COVID-19 patients pulled out of danger using antibody cockta
Updated : 5 years ago IST
New Delhi [India], June 3 (ANI): A Delhi Hospital on Tuesday pulled two high-risk senior citizen COVID-19 patients out of danger by administering Monoclonal Antibody Cocktail (MAC) therapy.
Read More
COVID-19: Delhi's Sir Gangaram Hospital begins monoclonal antibody cocktai
Updated : 5 years ago IST
New Delhi [India], June 1 (ANI): Delhi's Sir Gangaram Hospital on Tuesday commenced administration of Monoclonal Antibody Cocktail (MAC) to coronavirus patients, the medical facility said in a statement.
Read More
Eli Lilly's antibody cocktail drug gets emergency use nod in India
Updated : 5 years ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India on Tuesday announced that it has received emergency use approval in the country for its monoclonal antibody drug combination used for treating Covid-19 patients with mild to moderate symptoms.
Read More
Lilly India gets nod for use of monoclonal antibody drugs for treating Cov
Updated : 5 years ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India said on Tuesday it has received permission for restricted emergency use of its antibody drugs bamlanivimab 700 mg and etesevimab 1,400 mg in India for treatment of patients with mild to moderate coronavirus disease 2019 (Covid-19).
Read More
Monoclonal antibodies to treat COVID patients should always be used in pai
Updated : 5 years ago IST
New Delhi [India], May 31 (ANI): Monoclonal antibodies, recently introduced in India as an antibody therapy to treat COVID-positive patients, are being used to minimise mutation formation and should always be used in a pair, said Dr Nirmal K Ganguly, former Director-General of the Indian Cou
Read More